SILFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
1.13M
SUPN
Price
$48.35
Change
+$0.39 (+0.81%)
Updated
Oct 3 closing price
Capitalization
2.71B
36 days until earnings call
Interact to see
Advertisement

SILFF vs SUPN

Header iconSILFF vs SUPN Comparison
Open Charts SILFF vs SUPNBanner chart's image
Silo Wellness
Price$0.01
Change-$0.00 (-0.00%)
Volume$300
Capitalization1.13M
Supernus Pharmaceuticals
Price$48.35
Change+$0.39 (+0.81%)
Volume$939.44K
Capitalization2.71B
SILFF vs SUPN Comparison Chart in %
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SILFF vs. SUPN commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SILFF is a StrongBuy and SUPN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (SILFF: $0.01 vs. SUPN: $48.35)
Brand notoriety: SILFF and SUPN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SILFF: 100% vs. SUPN: 112%
Market capitalization -- SILFF: $1.13M vs. SUPN: $2.71B
SILFF [@Pharmaceuticals: Generic] is valued at $1.13M. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.71B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.89B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SILFF’s FA Score shows that 0 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • SILFF’s FA Score: 0 green, 5 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, SUPN is a better buy in the long-term than SILFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SUPN’s TA Score shows that 3 TA indicator(s) are bullish.

  • SUPN’s TA Score: 3 bullish, 4 bearish.

Price Growth

SILFF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

Reported Earning Dates

SUPN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($2.71B) has a higher market cap than SILFF($1.13M). SUPN has higher P/E ratio than SILFF: SUPN (41.70) vs SILFF (0.14). SUPN YTD gains are higher at: 33.711 vs. SILFF (0.000).
SILFFSUPNSILFF / SUPN
Capitalization1.13M2.71B0%
EBITDAN/A174M-
Gain YTD0.00033.711-
P/E Ratio0.1441.700%
RevenueN/A665M-
Total CashN/A523M-
Total DebtN/A31.8M-
FUNDAMENTALS RATINGS
SUPN: Fundamental Ratings
SUPN
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SILFFSUPN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
22%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
63%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFIIX18.070.13
+0.71%
Baron FinTech Institutional
FANIX50.630.31
+0.62%
Fidelity Advisor Energy I
ALVGX11.260.06
+0.54%
American Century Focused Lg Cap Val R5
LGCWX20.090.04
+0.20%
Lord Abbett Global Equity R6
VAFCX26.65-0.11
-0.41%
Invesco American Franchise C

SILFF and

Correlation & Price change

A.I.dvisor tells us that SILFF and SUPN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SILFF and SUPN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SILFF
1D Price
Change %
SILFF100%
N/A
SUPN - SILFF
27%
Poorly correlated
+0.81%
RDY - SILFF
21%
Poorly correlated
+0.64%
OGI - SILFF
20%
Poorly correlated
+0.53%
HLN - SILFF
10%
Poorly correlated
+0.79%
VTRS - SILFF
4%
Poorly correlated
+0.79%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DRRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DRRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+0.81%
DRRX - SUPN
32%
Poorly correlated
N/A
DVAX - SUPN
28%
Poorly correlated
N/A
SNDL - SUPN
27%
Poorly correlated
+1.98%
ACET - SUPN
27%
Poorly correlated
+0.80%
SILFF - SUPN
27%
Poorly correlated
N/A
More